Posts by: Alice Melão

Alice Melão

October 24, 2019October 24, 2019

Inhaled Ciprofloxacin May Help Prevent Bronchiectasis Exacerbation, but More Studies are Needed, Review Suggests

News

Treatment with inhaled ciprofloxacin medications — such as Aradigm’s Apulmiq or Bayer’s Ciprofloxacin DPI investigational therapies — holds potential to prevent acute worsening of respiratory problems in patients with bronchiectasis, ... Read more

April 18, 2019April 18, 2019

Nucala Can Help Manage Symptoms of Severe Eosinophilic Asthma with Bronchiectasis, Pilot Study Shows

News

Nucala (mepolizumab) can help manage the respiratory symptoms of patients with severe uncontrolled asthma and diagnosed bronchiectasis, results from a pilot study show. This finding suggests that targeting the signaling protein ... Read more

January 24, 2019January 24, 2019

Independent Review Supports Aqulmiq in Delaying Flares in NCFBE, Report Says

News

Treatment with Apulmiq (ciprofloxacin) can delay the first acute respiratory episode in non-cystic fibrosis bronchiectasis (NCFBE) patients with chronic Pseudomonas aeruginosa infection, a new independent analysis of ORBIT-4 trial data ... Read more

December 13, 2018December 13, 2018

Zambon’s Inhalable Antibiotic for Non-CF Bronchiectasis Gets Fast Track, QIDP Status from FDA

News

The U.S. Food and Drug Administration (FDA) granted Qualified Infectious Diseases Product (QIDP) and Fast Track designations to Zambon’s inhalable colistimethate sodium product to help prevent non-cystic fibrosis bronchiectasis (NCFBE) ... Read more

November 8, 2018November 8, 2018

New Probe Allows Safe, Easy Visualization of Infectious Bacteria in Lungs, Study Shows

News

A newly developed fluorescent probe allows the detection of infectious bacteria in human airways and lung’s air sacs within minutes, a study shows. This innovative diagnostic strategy was found to ... Read more

May 8, 2018May 8, 2018

SmartVest System Leads to Long-term Benefits for Bronchiectasis Patients, Study Shows

News

Long-term use of Electromed’s SmartVest Airway Clearance System reduces bronchiectasis-related exacerbations and improves patients’ quality of life, a recent study shows. SmartVest’s long-term benefits were reported in the study, “Incidence ... Read more

April 6, 2018April 6, 2018

European Regulators Agree to Review Aradigm’s Bronchiectasis Bacteria Therapy

News

The European Medicines Agency has agreed to review Aradigm Corporation’s Linhaliq as a treatment for non-cystic fibrosis bronchiectasis patients with chronic Pseudomonas aeruginosa lung infections. If the agency recommends its approval, ... Read more

February 8, 2018February 8, 2018

S. aureus Infection Not Strongly Linked to Decline in Bronchiectasis Patients, Study Reports

News

An airway infection caused by Staphylococcus aureus is not an independent risk factor for more severe disease in bronchiectasis patients, a study published in the Annals of the American Thoracic ... Read more

January 4, 2018January 4, 2018

FDA Advisory Group Set to Review Linhaliq, Potential Non-CF Bronchiectasis Treatment, on Jan. 11

News

A committee of the U.S. Food and Drug Administration (FDA) will review an application requesting that Linhaliq be approved to treat non-cystic fibrosis bronchiectasis (NCFBE) patients with chronic lung infections due to Pseudomonas ... Read more